Hong-Zhe Zhang
Overview
Explore the profile of Hong-Zhe Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wan C, Li L, Liu L, Jiang C, Zhang H, Wang J
J Endod
. 2021 Apr;
47(7):1118-1125.
PMID: 33895237
Introduction: Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) are considered important mediators of the periapical immune response to infection. This study aimed to clarify the putative relationship...
2.
Sun W, Feng S, Zhang H, Zhang H, Deng J
Shanghai Kou Qiang Yi Xue
. 2018 Aug;
27(2):195-199.
PMID: 30146649
Purpose: To evaluate the clinical performance of at-home bleaching and its application in combination with cold-light bleaching for esthetic management of fluorosed teeth，providing guidance for clinicians to choose the right...
3.
Zhang H, Kim M, Guo L, Serebruany V
Blood Coagul Fibrinolysis
. 2016 Jul;
28(1):56-61.
PMID: 27380588
Clopidogrel response variability (CRV) is well documented, and may affect clinical outcomes. Impact of genetic polymorphisms is important for assessing and predicting CRV. The extensive evidence indicates the importance of...
4.
Zhang H, Kim M, Jeong Y
Platelets
. 2013 Aug;
25(4):292-9.
PMID: 23971791
Abstract An accumulating number of studies are revealing that platelet reactivity above specific cut-off scores leads to exponentially increased rates of post-percutaneous coronary intervention (PCI) ischemic events. To evaluate the...
5.
Zhang H, Kim M, Han J, Jeong Y
Platelets
. 2013 Aug;
25(4):285-91.
PMID: 23971745
Published data suggests that the presence of CYP2C19*2 or *3 loss of function (LOF) alleles is indicative of increased platelet aggregation and a higher risk of adverse cardiovascular events after...
6.
Lee D, Kim M, Park T, Park J, Park K, Zhang H, et al.
Trials
. 2013 Mar;
14:62.
PMID: 23448344
Background: Patients with reduced responsiveness to clopidogrel often have diminished platelet inhibition, a factor associated with increased rates of major adverse cardiovascular events. Clinical trials that have focused on reducing...
7.
Kim M, Zhang H, Jung D
Circ J
. 2013 Feb;
77(5):1253-9.
PMID: 23363643
Background: Previous studies involving a loading dose (LD) of 60 mg prasugrel have suggested that active metabolite exposure and pharmacodynamic responses may be higher in persons of Asian ethnicity than...
8.
Kim S, Zhang H, Kim C, Kim J, Kim M
Int J Cardiol
. 2012 Dec;
168(2):1062-9.
PMID: 23218573
Background: We previously reported that amniotic mesenchymal stem cells (AMMs) possess high angio-vasulogenic properties. In this study, we investigated the chemotactic abilities of AMMs for improved cardiac function and regenerative...
9.
Kim S, Lee D, Yu L, Zhang H, Kim C, Kim J, et al.
Cardiovasc Res
. 2012 Aug;
95(4):495-506.
PMID: 22886775
Aims: In this study, our aim was to evaluate the angio-vasculogenic properties of human adipose tissue-derived mesenchymal stem cells overexpressing the granulocyte chemotactic protein (GCP)-2 (hASCs/GCP-2) and to determine possible...
10.
Kim S, Zhang H, Guo L, Kim J, Kim M
PLoS One
. 2012 Jul;
7(7):e41105.
PMID: 22815931
Although human amniotic mesenchymal stem cells (AMMs) have been recognised as a promising stem cell resource, their therapeutic potential for wound healing has not been widely investigated. In this study,...